Vincent Grégoire

Vincent Grégoire's AcademicInfluence.com Rankings

Vincent Grégoire

Medical

#2954

World Rank

#3401

Historical Rank

Radiology

#57

World Rank

#68

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Vincent Grégoire Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Vincent Grégoire's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. (2004) (663)
CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. (2003) (640)
Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010) (543)
Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. (2014) (521)
A gradient-based method for segmenting FDG-PET images: methodology and validation (2007) (422)
Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. (2003) (397)
CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. (2015) (369)
Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. (2000) (350)
Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. (2006) (331)
Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. (2008) (321)
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. (2012) (310)
Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. (2011) (273)
Adaptive radiotherapy of head and neck cancer. (2010) (250)
Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010) (240)
Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. (2010) (215)
PET-based treatment planning in radiotherapy: a new standard? (2007) (215)
Comparison of 12 deformable registration strategies in adaptive radiation therapy for the treatment of head and neck tumors. (2008) (213)
Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumors. (2001) (211)
Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. (2007) (210)
Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2020) (208)
State of the art on dose prescription, reporting and recording in Intensity-Modulated Radiation Therapy (ICRU report No. 83). (2011) (205)
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. (2017) (194)
Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies. (2006) (190)
Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. (2003) (187)
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. (2017) (175)
The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. (2006) (170)
Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple? (2001) (168)
Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. (2005) (166)
Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: comparison between CT-scan and MRI. (2005) (164)
Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. (2007) (164)
Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapies. (1993) (163)
Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches, CT and surgical specimens. (2011) (163)
Caveolin-1 Expression Is Critical for Vascular Endothelial Growth Factor–Induced Ischemic Hindlimb Collateralization and Nitric Oxide–Mediated Angiogenesis (2004) (160)
Classification and evaluation strategies of auto‐segmentation approaches for PET: Report of AAPM task group No. 211 (2017) (149)
Advances in Radiotherapy for Head and Neck Cancer. (2015) (147)
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement (2020) (143)
Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: accuracy, reproducibility and consistency. (2003) (134)
Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies. (2006) (127)
Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation. (2010) (119)
Comparison of external radiotherapy, laser microsurgery and partial laryngectomy for the treatment of T1N0M0 glottic carcinomas: a retrospective evaluation. (1998) (115)
Intensity-modulated radiation therapy for head and neck carcinoma. (2007) (114)
Oropharyngeal carcinoma related to human papillomavirus (2010) (114)
Atlas-based delineation of lymph node levels in head and neck computed tomography images. (2008) (112)
PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014. (2015) (112)
Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. (2002) (111)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group. (2016) (109)
Strategies to reduce long‐term postchemoradiation dysphagia in patients with head and neck cancer: An evidence‐based review (2014) (106)
Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors. (2012) (106)
Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive? (2012) (103)
Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. (2019) (97)
Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy (2013) (94)
Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and promotes gene delivery (2002) (92)
Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice. (2013) (89)
The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease. (2012) (88)
Adaptive functional image-guided IMRT in pharyngo-laryngeal squamous cell carcinoma: is the gain in dose distribution worth the effort? (2011) (88)
A prospective clinical study of 18 F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy (2014) (86)
Advances in the management of squamous cell carcinoma of the head and neck (2014) (85)
A pre-clinical assessment of an atlas-based automatic segmentation tool for the head and neck. (2009) (85)
Early reoxygenation in tumors after irradiation: determining factors and consequences for radiotherapy regimens using daily multiple fractions. (2005) (81)
Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect. (2005) (80)
Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT. (2004) (78)
Rotterdam and Brussels CT-based neck nodal delineation compared with the surgical levels as defined by the American Academy of Otolaryngology-Head and Neck Surgery. (2004) (76)
Nitric oxide as a radiosensitizer: Evidence for an intrinsic role in addition to its effect on oxygen delivery and consumption (2004) (76)
Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry. (2012) (73)
Chemo-radiotherapy: radiosensitizing nucleoside analogues (review). (1999) (73)
A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach. (2013) (72)
International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma. (2019) (70)
Is there any future in radiotherapy planning without the use of PET: unraveling the myth... (2004) (67)
Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment. (2004) (67)
Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy. (2015) (65)
Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma (2009) (62)
The limitation of PET imaging for biological adaptive-IMRT assessed in animal models. (2009) (59)
Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: A planning study (2015) (59)
Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy. (2006) (57)
Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma (2013) (57)
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement (2020) (57)
RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison (2013) (57)
Effect of chromosome size on aberration levels caused by gamma radiation as detected by fluorescence in situ hybridization. (1994) (55)
Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer. (2009) (55)
Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth (2015) (52)
[(18) F]CuCF3 : a [(18) F]trifluoromethylating agent for arylboronic acids and aryl iodides. (2014) (52)
Clinical use of PET-CT data for radiotherapy planning: what are we looking for? (2010) (52)
Is PET-based treatment planning the new standard in modern radiotherapy? The head and neck paradigm. (2006) (50)
The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo. (1994) (50)
[18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model (2009) (49)
Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or a repair inhibition of DNA double-strand breaks as measured by pulsed-field gel electrophoresis. (1998) (49)
Glucocorticoids Modulate Tumor Radiation Response through a Decrease in Tumor Oxygen Consumption (2007) (48)
De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies (2020) (48)
Gefitinib plus cisplatin and radiotherapy in previously untreated head and neck squamous cell carcinoma: a phase II, randomized, double-blind, placebo-controlled study. (2011) (48)
Treatment of head and neck cancer in the elderly (2010) (47)
Anatomical bases for the radiological delineation of lymph node areas. Major collecting trunks, head and neck. (2007) (46)
International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ‐HN43: Phase IV (2018) (46)
Nitric oxide-mediated increase in tumor blood flow and oxygenation of tumors implanted in muscles stimulated by electric pulses. (2003) (45)
Selection and delineation of target volumes in head and neck tumors: beyond ICRU definition. (2003) (45)
Intestinal crypt regeneration in mice: a biological system for quality assurance in non-conventional radiation therapy. (2004) (45)
The effect of 2'-2' difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity. (1999) (45)
Measurements of radiobiological effectiveness in the 85 MeV proton beam produced at the cyclotron CYCLONE of Louvain-la-Neuve, Belgium. (1996) (45)
Potentiation of radiation‐induced regrowth delay by isosorbide dinitrate in FSaII murine tumors (2003) (45)
Cost-minimization analysis of treatment options for T1N0 glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomy. (1999) (45)
Impact of cyclic hypoxia on HIF‐1α regulation in endothelial cells – new insights for anti‐tumor treatments (2009) (44)
Synthesis of [18F]-labeled EF3 [2-(2-nitroimidazol-1-yl)-N-(3,3,3-trifluoropropyl)-acetamide], a marker for PET detection of hypoxia. (2001) (44)
Decrease in Tumor Cell Oxygen Consumption after Treatment with Vandetanib (ZACTIMA™; ZD6474) and its Effect on Response to Radiotherapy (2009) (42)
Image guidance in radiation therapy for better cure of cancer (2020) (42)
Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: a retrospective study (2018) (42)
Prognostic factors and assessment of staging systems for head and neck soft tissue sarcomas in adults. (2010) (41)
Biological Basis for Increased Sensitivity to Radiation Therapy in HPV-Positive Head and Neck Cancers (2014) (41)
Parapharyngeal metastases from thyroid cancer. (2004) (40)
In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors. (2003) (40)
Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma. (2018) (39)
Determination of tumour hypoxia with [18F]EF3 in patients with head and neck tumours: a phase I study to assess the tracer pharmacokinetics, biodistribution and metabolism (2008) (39)
Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery (2006) (38)
Efficient multi-modal dense field non-rigid registration: alignment of histological and section images (2005) (38)
Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome (2014) (38)
Edge-Preserving Filtering of Images with Low Photon Counts (2008) (38)
Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3 (2004) (37)
Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer (14)C-EF3 in animal tumor models. (2010) (37)
Primary combined squamous and small cell carcinoma of the larynx: report of two cases and discussion of treatment modalities (2006) (35)
Dose- and time-dependent gene expression alterations in prostate and colon cancer cells after in vitro exposure to carbon ion and X-irradiation (2014) (35)
(89)Zr-labeled anti-endoglin antibody-targeted gold nanoparticles for imaging cancer: implications for future cancer therapy. (2014) (35)
PET in radiotherapy planning: particularly exquisite test or pending and experimental tool? (2010) (34)
Radiomics: Principles and radiotherapy applications. (2019) (33)
Carbon ion irradiation of the human prostate cancer cell line PC3: A whole genome microarray study (2014) (33)
Reprogramming of tumor metabolism by targeting mitochondria improves tumor response to irradiation (2015) (32)
Conservation laryngeal surgery for selected pyriform sinus cancer. (2004) (32)
Molecular Imaging-Guided Radiotherapy for the Treatment of Head-and-Neck Squamous Cell Carcinoma: Does it Fulfill the Promises? (2018) (32)
Radiobiological rationale and patient selection for high-LET radiation in cancer therapy. (2004) (31)
Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell death. (2010) (30)
Helical tomotherapy for SIB and hypo-fractionated treatments in lung carcinomas: a 4D Monte Carlo treatment planning study. (2012) (30)
Implementation of hypoxia PET imaging in radiation therapy planning. (2013) (29)
Captopril and S-nitrosocaptopril as potent radiosensitizers: Comparative study and underlying mechanisms. (2010) (29)
Use of 5-[76Br]bromo-2'-fluoro-2'-deoxyuridine as a ligand for tumour proliferation: validation in an animal tumour model (2001) (29)
Effects of irradiation on bone remodelling around mandibular implants: an experimental study in dogs. (2006) (29)
Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors. (1993) (29)
Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine. (1994) (29)
Molecular Imaging in Radiotherapy Planning for Head and Neck Tumors (2011) (28)
The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck (2014) (28)
PET imaging biomarkers in head and neck cancer (2015) (28)
Implant osseointegration in the irradiated mandible. A comparative study in dogs with a microradiographic and histologic assessment. (2002) (28)
Long-term update of the 24954 EORTC phase III trial on larynx preservation. (2016) (27)
EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility. (2012) (27)
Evaluation of MVCT protocols for brain and head and neck tumor patients treated with helical tomotherapy. (2009) (27)
Dentalmaps: automatic dental delineation for radiotherapy planning in head-and-neck cancer. (2012) (27)
Potential role of hypoxia imaging using (18)F-FAZA PET to guide hypoxia-driven interventions (carbogen breathing or dose escalation) in radiation therapy. (2014) (27)
Digital pathology: elementary, rapid and reliable automated image analysis (2016) (26)
Implants placed in an irradiated dog mandible: a morphometric analysis. (2000) (26)
Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy. (2020) (26)
The expanding role of fludarabine in hematologic malignancies. (1994) (26)
Role of deoxycytidine kinase (dCK) activity in gemcitabine's radioenhancement in mice and human cell lines in vitro. (2002) (26)
The EORTC module for quality of life in patients with thyroid cancer: phase III. (2017) (26)
Fludarabine improves the therapeutic ratio of radiotherapy in mouse tumors after single-dose irradiation. (1994) (26)
A Fast Hydrogen Sulfide–Releasing Donor Increases the Tumor Response to Radiotherapy (2015) (25)
RBE variation between fast neutron beams as a function of energy. Intercomparison involving 7 neutrontherapy facilities. (1996) (25)
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma. (1994) (25)
Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412. (2020) (25)
Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models. (2008) (25)
Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors (2016) (25)
Detection of tumour hypoxia: comparison between EF5 adducts and [18F]EF3 uptake on an individual mouse tumour basis (2006) (25)
Radiosynthesis and validation of (±)-[18F]-3-fluoro-2-hydroxypropionate ([18F]-FLac) as a PET tracer of lactate to monitor MCT1-dependent lactate uptake in tumors (2017) (24)
Intensity modulated radiation therapy in head and neck squamous cell carcinoma: state of the art and future challenges. (2005) (24)
Development of clinical trial protocols involving advanced radiation therapy techniques: the European Organisation for Research and Treatment of Cancer Radiation Oncology Group approach. (2012) (24)
The role of computational methods for automating and improving clinical target volume definition. (2020) (24)
First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-II. (2010) (23)
A proposal for redefining the boundaries of level V in the neck: is dissection of the apex of level V necessary in mucosal squamous cell carcinoma of the head and neck? (2002) (23)
Point/Counterpoint: Do We De-escalate Treatment of HPV-Associated Oropharynx Cancer Now? And How? (2019) (23)
Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2010) (23)
Estimation of the deformations induced by articulated bodies: Registration of the spinal column (2007) (22)
Dose prescription, reporting and recording in intensity-modulated radiation therapy: a digest of the ICRU Report 83 (2011) (21)
Determination of tumour hypoxia with the PET tracer [18F]EF3: improvement of the tumour-to-background ratio in a mouse tumour model (2007) (21)
Organ Preservation and Late Functional Outcome in Oropharyngeal Carcinoma: Rationale of EORTC 1420, the “Best of” Trial (2019) (21)
Monitoring Tumor Response to Carbogen Breathing by Oxygen-Sensitive Magnetic Resonance Parameters to Predict the Outcome of Radiation Therapy: A Preclinical Study. (2016) (21)
International Recommendations on Re-irradiation by Intensity-modulated Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma. (2021) (21)
Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer. (2019) (21)
A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma. (2002) (21)
Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer (2020) (21)
Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance. (2019) (20)
Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071-24071 prospective study for head and neck cancer. (2014) (20)
Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma. (2021) (20)
Evaluation of the radiobiological impact of anatomic modifications during radiation therapy for head and neck cancer: can we simply summate the dose? (2010) (20)
Thyroid Status is a Key Modulator of Tumor Oxygenation: Implication for Radiation Therapy (2007) (20)
Predictive value of (18)F-FAZA PET imaging for guiding the association of radiotherapy with nimorazole: a preclinical study. (2015) (20)
Immobilization device for in vivo and in vitro multimodality image registration of rodent tumors. (2008) (19)
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis. (2021) (19)
Higher Initial DNA Damage and Persistent Cell Cycle Arrest after Carbon Ion Irradiation Compared to X-irradiation in Prostate and Colon Cancer Cells (2016) (19)
Generation of prescriptions robust against geometric uncertainties in dose painting by numbers (2015) (19)
The potential of helical tomotherapy in the treatment of head and neck cancer. (2013) (19)
Kinetics of mouse jejunum radiosensitization by 2′,2′-difluorodeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell cycle redistribution in crypt cells (1997) (19)
Carotid stenting for impending carotid blowout: suitable supportive care for head and neck cancer patients? (2005) (18)
Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: a rationale for combination with radiation therapy. (2012) (18)
High prevalence of SDHB mutations in head and neck paraganglioma in Belgium (2008) (18)
A phase I-II trial of induction chemotherapy with carboplatin and fluorouracil in locally advanced head and neck squamous cell carcinoma: a report from the UCL-Oncology Group, Belgium. (1991) (18)
Practical clinical guidelines for contouring the trigeminal nerve (V) and its branches in head and neck cancers. (2019) (17)
Epithelial–myoepithelial carcinoma of the submandibular gland with symptomatic lung metastases treated with chemotherapy (2006) (17)
Intensity-modulated radiation therapy in head and neck squamous cell carcinoma: an adaptation of 2-dimensional concepts or a reconsideration of current clinical practice. (2004) (17)
Effect of intra-peritoneal fludarabine on rat spinal cord tolerance to fractionated irradiation. (1995) (17)
Preclinical safety and antitumor efficacy of insulin combined with irradiation. (2006) (16)
Accelerated versus Conventional Radiotherapy with Concomitant Chemotherapy in Locally Advanced Head and Neck Carcinomas: Results of a Phase III Randomized Trial (2008) (16)
Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc (2017) (16)
Selective neck dissection in the management of the neck after (chemo)radiotherapy for advanced head and neck cancer. Proposal for a classification update (2010) (16)
Head and Neck Cancer International Group (HNCIG) Consensus Guidelines for the delivery of postoperative radiation therapy in complex cutaneous squamous cell carcinoma of the head and neck (cSCCHN). (2020) (16)
The radioenhancement of two human head and neck squamous cell carcinomas by 2'-2' difluorodeoxycytidine (gemcitabine; dFdC) is mediated by an increase in radiation-induced residual chromosome aberrations but not residual DNA DSBs. (2003) (15)
Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure. (2017) (15)
Non‐invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism (2016) (15)
Comorbidity in head and neck cancer: Is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study? (2020) (15)
Current practice in proton therapy delivery in adult cancer patients across Europe. (2021) (15)
New initiatives with fludarabine monophosphate in hematologic malignancies. (1993) (15)
Fitter Mitochondria Are Associated With Radioresistance in Human Head and Neck SQD9 Cancer Cells (2020) (15)
Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine. (1996) (15)
Radiobiological intercomparison of p(45)+Be and p(65)+Be neutron beams for lung tolerance in mice after single and fractionated irradiation. (1993) (14)
Comparison of CT- and FDG-PET-defined GT: in regard to Paulino et al. (Int J Radiat Oncol Biol Phys 2005;61:1385-1392). (2005) (14)
Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy (2003) (14)
Alginate moulding: an empirical method for magnetic resonance imaging/positron emission tomography co-registration in a tumor rat model. (2008) (14)
Long-Term In Vivo Monitoring of Adult-Derived Human Liver Stem/Progenitor Cells by Bioluminescence Imaging, Positron Emission Tomography, and Contrast-Enhanced Computed Tomography. (2017) (14)
Prevalence of lymph nodes in the apex of level V: A plea against the necessity to dissect the apex of level V in mucosal head and neck cancer (2005) (14)
Synthesis of new 18F-radiolabeled silicon-based nitroimidazole compounds. (2013) (14)
Biodistribution of (125)I-labeled anti-endoglin antibody using SPECT/CT imaging: Impact of in vivo deiodination on tumor accumulation in mice. (2016) (13)
Multimodality Imaging Identifies Distinct Metabolic Profiles In Vitro and In Vivo1 (2016) (13)
KEYNOTE-412: Pembrolizumab (pembro) in combination with chemoradiation versus chemoradiation alone in locally advanced head and neck squamous cell carcinoma (LA-HNSCC). (2017) (13)
Surgical quality assurance in head and neck cancer trials: an EORTC Head and Neck Cancer Group position paper based on the EORTC 1420 'Best of' and 24954 'larynx preservation' study. (2018) (13)
Effect of gemcitabine on the tolerance of the lung to single-dose irradiation in C3H mice. (1999) (12)
General principles for prescribing, recording and reporting a therapeutic irradiation. (2004) (12)
Alteration of the blood-brain barrier after irradiation: implication in boron neutron capture therapy. (1993) (12)
Role of 2'-2' difluorodeoxycytidine (gemcitabine)-induced cell cycle dysregulation in radio-enhancement of human head and neck squamous cell carcinomas. (2004) (12)
Multimodal imaging of tumor response to sorafenib combined with radiation therapy: comparison between diffusion-weighted MRI, choline spectroscopy and 18F-FLT PET imaging. (2013) (12)
Potentiation of radiotherapy by a localized antiangiogenic gene therapy. (2013) (12)
Impact of image coregistration with computed tomography (CT), magnetic resonance (MR) and positron emission tomography with fluorodeoxyglucose (FDG-PET) on delineation of GTV’s in oropharyngeal, laryngeal and hypopharyngeal tumors (2002) (11)
Reprint of "Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up". (2020) (11)
Use of Xanthinol Nicotinate as a co‐treatment for radio‐ and chemo‐therapy in experimental tumors (2010) (11)
The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited (2017) (11)
Preclinical Evaluation of White Led-Activated Non-porphyrinic Photosensitizer OR141 in 3D Tumor Spheroids and Mouse Skin Lesions (2018) (11)
Evaluation of fully automated a priori MCO treatment planning in VMAT for head-and-neck cancer. (2021) (11)
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer (2021) (10)
Perfluorinated markers for hypoxia detection: synthesis of sulfur-containing precursors and [18F]-labelling. (2005) (10)
Predictive classifier for intensive treatment of head and neck cancer (2020) (10)
Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer. (2005) (10)
Radiobiological intercomparisons of fast neutron beams used in therapy. (1989) (10)
Microsatellite alterations in head and neck squamous cell carcinoma and relation to expression of pimonidazole, CA IX and GLUT-1. (2006) (10)
UK Head and neck cancer surgical capacity during the second wave of the COVID—19 pandemic: Have we learned the lessons? COVIDSurg collaborative (2021) (10)
Rodent Rhabdomyosarcoma: Comparison Between Total Choline Concentration at H-MRS and [18F]-fluoromethylcholine Uptake at PET Using Accurate Methods for Collecting Data (2010) (9)
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials. (2017) (9)
Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models (2016) (9)
Choosing surgery or radiotherapy for oropharyngeal squamous cell carcinoma: is the issue definitely settled? (2019) (9)
The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying—the head and neck cancer model (2020) (9)
Removal of local field gradient artefacts in BOLD contrast imaging of head and neck tumours. (2002) (8)
Adaptive Responses to Monotherapy in Head and Neck Cancer: Interventions for Rationale-Based Therapeutic Combinations. (2019) (8)
[Target-volume selection and delineation in the cervico-maxillo-facial region: beyond the concepts of the ICRU]. (2002) (8)
First report on the patient database of the identification of the genetic pathways involved in patients overreacting to radiotherapy: GENEPI-II (2009) (8)
Fast Helical Tomotherapy in a head and neck cancer planning study: is time priceless? (2015) (8)
The increase in tumor oxygenation under carbogen breathing induces a decrease in the uptake of [(18)F]-fluoro-deoxy-glucose. (2015) (8)
Improved survival in patients with head and neck cancer treated in higher volume centres: A population-based study in Belgium. (2020) (7)
Radiation-induced apoptosis in tumors: effect of radiation modulating agents. (1997) (7)
Caveolin-1 Expression Is Critical for VEGF-Induced Ischemic Hindlimb Collateralization and Nitric Oxide – Mediated Angiogenesis (2004) (7)
Functional image-guided intensity modulated radiation therapy: integration of the tumour microenvironment in treatment planning. (2009) (7)
Intraoperative validation of CT-based lymph nodal levels, sublevels IIa and IIb: is it of clinical relevance in selective radiation therapy? (2005) (7)
Clinical implementation of deep-learning based auto-contouring tools-Experience of three French radiotherapy centers. (2021) (7)
Unmet Needs and Perspectives in Oral Cancer Prevention (2022) (6)
Radiation Therapy and Management of the Cervical Lymph Nodes and Malignant Skull Base Tumors (2010) (6)
Early (72‐Hour) detection of radiotherapy‐induced changes in an experimental tumor model using diffusion‐weighted imaging, diffusion tensor imaging, and Q‐space imaging parameters: A comparative study (2012) (6)
2′-deoxy-2′-[18F] fluoro-D-glucose positron emission tomography, diffusion-weighted magnetic resonance imaging, and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck (2018) (6)
Radiobiological comparison of fast neutron beams used in therapy. Survey of the published data. (1990) (6)
Pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma: The phase 3 KEYNOTE-412 study. (2018) (6)
Regarding Davis et al.: Assessment of (18)F PET signals for automatic target volume definition in radiotherapy treatment planning. (2007) (6)
Head and Neck Cancer in Belgium: Quality of Diagnostic Management and Variability Across Belgian Hospitals Between 2009 and 2014 (2019) (5)
Abstract CT163: KEYNOTE-412: Pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma (2018) (5)
Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma (2020) (5)
Tumor reoxygenation following administration of the EGFR inhibitor, gefitinib, in experimental tumors. (2013) (5)
Lack of differences in radiation-induced immunogenicity parameters between HPV-positive and HPV-negative human HNSCC cell lines. (2017) (5)
DW-MRI and (18) F-FLT PET for early assessment of response to radiation therapy associated with hypoxia-driven interventions. Preclinical studies using manipulation of oxygenation and/or dose escalation. (2016) (5)
EORTC Radiation Oncology Group: 50 years of continuous accomplishments (2012) (5)
Atlas-based automatic segmentation (ABAS) of head and neck (H&N) structures in conformal radiotherapy (CRT): Atlas development and preliminary results in clinical context (2007) (5)
Blood-brain-barrier impairment after irradiation: implication in boron neutron capture therapy. (1989) (5)
Early monitoring of external radiation therapy by [18F]-fluoromethylcholine positron emission tomography and 3-T proton magnetic resonance spectroscopy: an experimental study in a rodent rhabdomyosarcoma model. (2010) (5)
KEYNOTE-412: Phase III study of pembrolizumab plus chemoradiation vs chemoradiation alone for locally advanced head and neck squamous cell carcinoma (HNSCC). (2018) (5)
Investigating the potential of deep learning for patient-specific quality assurance of salivary gland contours using EORTC-1219-DAHANCA-29 clinical trial data (2021) (5)
Technologic Advances in External Beam Radiotherapy for Head and Neck Cancer (2013) (5)
Molecular-targeted agents for enhancing tumour response (2009) (5)
Combined radiotherapy and chemotherapy (2009) (5)
How to minimize morbidity in radiotherapy of pharyngolaryngeal tumors? (2016) (4)
Variation of Neutron RBE as a Function of Energy for Different Biological Systems: A Review (1992) (4)
[Recommendations for the definition of target volumes on computerized dosimetry in oropharyngeal cancers]. (2004) (4)
What is the most effective treatment for head and neck squamous cell carcinoma? An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups (2017) (4)
Impact of hypoxia in head and neck cancer radiotherapy (2017) (4)
BEST OF: A phase III study assessing the best of radiotherapy (Intensity Modulated RadioTherapy, IMRT) compared to the best of surgery (Trans-Oral Surgery, TOS) in patients with T1-T2, N0 oropharyngeal squamous cell carcinoma (OPSCC). (2018) (4)
Recommendations for postoperative radiotherapy in head & neck squamous cell carcinoma in the presence of flaps: a GORTEC internationally-reviewed HNCIG-endorsed consensus. (2021) (4)
Volumetric and dosimetric comparison of two delineation guidelines for the radiation treatment of laryngeal squamous cell carcinoma (2019) (4)
Time of PTV is ending, robust optimization comes next. (2020) (4)
The role of gemcitabine-induced cell cycle synchronization in radiosensitization of A SCC61 human head & neck squamous carcinoma cell (HNSCC) line (1997) (4)
Combined radiotherapy and chemotherapy (2009) (4)
New challenge of developing combined radio-drug therapy. (2014) (4)
Selection and Delineation of Lymph Node Target Volumes in Head and Neck Conformal and Intensity-Modulated Radiation Therapy (2004) (4)
Selection and Delineation of Target Volumes in Intensity-Modulated Radiation Therapy for Nasopharyngeal Cancer (2010) (3)
Early repair kinetics of intestine and lung in mice, after fast neutron and photon irradiation. (1989) (3)
[Selection and delineation of lymph node target volumes in head and neck neoplasms]. (2001) (3)
[Impact of reconstructive or minimal invasive surgery on the assessment of current definitions of postoperative clinical target volume for head and neck cancers]. (2020) (3)
Head and neck multimodality volumes visualization methods (2002) (3)
[Lymph node metastases from squamous cell carcinoma of unknown primary site. Is it time to change of paradigm?]. (2014) (3)
Helical tomotherapy in head and neck cancer: a European single-center experience. (2015) (3)
18F-Fluorodeoxyglucose Positron Emission Tomography of Head and Neck Cancer: Location and HPV Specific Parameters for Potential Treatment Individualization (2022) (3)
[Potential place of FDG-PET for the GTV delineation in head and neck and lung cancers]. (2009) (3)
Chapter 40 – Management of the Neck (2011) (3)
Detailed patient-individual reporting of lymph node involvement in oropharyngeal squamous cell carcinoma with an online interface (2021) (3)
A Blinded Prospective Evaluation Of Clinical Applicability Of Deep Learning-Based Auto Contouring Of OAR For Head and Neck Radiotherapy (2020) (3)
Biomarkers of radioresistance in head and neck squamous cell carcinomas (2022) (3)
Special section on intensity-modulated radiation therapy for head and neck cancer (IMRT). (2019) (3)
[Present trends in cancer therapy with high-LET radiations] (1996) (3)
Comparison of atlas-based and deep learning methods for organs at risk delineation on head-and-neck CT images using an automated treatment planning system. (2022) (3)
Molecular targeted agents for enhancing tumour response (2009) (3)
2020 Is 18F-FDG a surrogate tracer to measure tumor hypoxia? Comparison with the hypoxic tracer 14C-EF3 in animal tumour models (2009) (3)
Radiobiology Studies at Petten: Status on Cell Culture, Mice and Dog Experiments (1992) (3)
PD-0441 TARGET VOLUME DELINEATION BASED ON 18FDG PET FOR LOCALLY ADVANCED HEAD AND NECK CANCER TREATED BY CHEMO-RADIOTHERAPY (2012) (3)
Multidisciplinary Management of Hypopharyngeal Carcinoma (2011) (3)
392 poster INTERNATIONAL IMRT CREDENTIALING BY PHYSICAL PHANTOM IRRADIATION: THE EORTC ROG EXPERIENCE (2011) (2)
OC-0278 Accelerated CH-RT with/without nimorazole for p16- HNSCC: the randomized DAHANCA 29-EORTC 1219 trial (2021) (2)
The role of PET for predicting nodal response in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) treated with chemoradiotherapy (CRT): Results of a prospective multicenter trial. (2017) (2)
Teaching Session A: Target Volume Selection and Delineation in Head and Neck Tumors: Beyond ICRU Definition. (2007) (2)
Implementation of intensity-modulated radiation therapy in head and neck tumors: what are the important data for biological optimization? (2004) (2)
Nuclear Data Relevant to Particle Radiation Therapy Today and to Morrow (1992) (2)
Conformal radiotherapy in head and neck tumors: increased tumor control and decreased morbidity? (1999) (2)
Boron Concentration Measurements for the Petten BNCT Project (1992) (2)
Treatment patterns in elderly patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results from an EORTC led survey. (2018) (2)
Concurrent Chemoradiation Therapy Versus Acceleration of Radiation Therapy With or Without Concurrent Chemotherapy in Locally Advanced Head and Neck Carcinoma (GORTEC 99-02): 7-Year Survival Data From a Phase 3 Randomized Trial and Prognostic Factors (2016) (2)
Comparison of CT- and FDG-PET-defined GT: In regard to Paulino et al. Author's reply (2005) (2)
344 MOLECULAR IMAGING IN PLANNING HEAD AND NECK CANCER TREATMENT (2012) (2)
Oropharyngeal, hypopharyngeal and laryngeal cancer: diagnosis, treatment and follow-up (2015) (2)
Quality assurance of radiotherapy in the ongoing EORTC 1420 “Best of” trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedure (2021) (2)
Comparative Pharmacokinetics and Distribution Studies of Boric Acid, L-BPA and BSH in Two Murine Tumour Models (1992) (2)
Selective irradiation of the neck validation of CT-based neck nodal delineation Rotterdam/Brussels consensus guidelines (2002) (2)
Editorial: Oropharyngeal carcinoma related to human papillomavirus: Incidence is increasing rapidly, with implications for prognosis and policy (2010) (2)
Implants placed in irradiated dog's mandible: morphometric examination (1998) (2)
In regard to Ciernik et al.: Automated functional image-guided radiation treatment planning for rectal cancer (Int J Radiat Oncol Biol Phys 2005;62:893-900). (2006) (2)
PP27. Cost minimization analysis of treatment of T1N0 glottic squamous cell carcinomas: Comparison between radiotherapy, laser microsurgery and partial laryngectomy (1997) (2)
[Current data and perspectives on positron emission tomography oncology-radiotherapy]. (1999) (2)
Predictor of effectiveness of treatment intensification on overall survival in head and neck cancer (HNC). (2018) (1)
Phase 3 KEYNOTE-412 trial: Pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) (2017) (1)
Conservation surgery for pyriform sinus cancer (2000) (1)
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic (2022) (1)
Patterns and quality of care for head and neck cancer in Belgium: A population-based study. (2021) (1)
Salivary gland cancers in elderly patients: challenges and therapeutic strategies (2022) (1)
Treatment patterns in older patients with locally advanced head and neck squamous cell carcinoma: Results from an EORTC led survey. (2021) (1)
Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc (2017) (1)
A dataset on patient-individual lymph node involvement in oropharyngeal squamous cell carcinoma (2022) (1)
Arterioles : Implications for Cancer Treatment Endothelin-1 Is a Critical Mediator of Myogenic Tone in Tumor (2004) (1)
Reply to the letter to the editor from Palazzi et al. (2004) (1)
35 Metastatic neck nodal carcinoma of unknown primary: which radiotherapy is needed? (2009) (1)
Somatic Mutations Induced in Tradescantia By Small Neutron Doses (1984) (1)
Upright patient positioning for pelvic radiotherapy treatments (2022) (1)
The Use of Premature Chromosome Condensation and Chromosome Painting to Understand Chromosome Exchange Formation (1994) (1)
Prospective validation of an institutional treatment strategy for T1N0M0 glottic carcinoma. (2019) (1)
Impact of Oxygenation Status on 18F-FDG Uptake in Solid Tumors. (2016) (1)
182 oral EORTC RADIOTHERAPY QUALITY ASSURANCE PLATFORM: ESTABLISHMENT OF AN INTEGRATED CENTRAL REVIEW FACILITY (2011) (1)
Improvement of delineation quality of organs at risk in head and neck using the consensus guidelines (2016) (1)
Prognostic impact of extranodal extension in resected head and neck squamous cell carcinomas in the era of postoperative chemoradiation: A retrospective monocentric study. (2021) (1)
PH-0328 Current practice for selection of adult patients for proton therapy across Europe (2021) (1)
Construction of a Dental Atlas for Automatic Teeth Segmentation to Improve Post-irradiation Dental Care Management (2010) (1)
Reply to sanguineti regarding the manuscript untitled "Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma". (2021) (1)
PH-0288: Independent external validation of a logistic regression NTCP model for grade 3 oral mucositis (2020) (0)
Which imaging is needed for planning head and neck squamous cell carcinoma: a 2004 update (2004) (0)
Survey of the Adoption of the UICC/AJCC 8th Edition TNM for Head and Neck Cancer: The User’s Initial Experience (2019) (0)
GD2. The node-negative neck: To operate or not to operate (2011) (0)
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-Fluorouracil with or without docetaxel : retrospective analysis of EORTC24971 study (2015) (0)
329Effect of 2′,2′-difluorodeoxycytidine (Gemcitabine) on in vivo radiotolerance of mouse jejunum, and its association with the pharmacodynamics of DNA synthesis inhibition (1996) (0)
List of Referees, 2009 (2010) (0)
Re-assessment of tumor volume during radiotherapy with anatomic and functional imaging in pharyngolaryngeal SCC: impact on dose distribution (2004) (0)
Progress in radiotherapy technology for non-radiation oncologists (2007) (0)
SP-026: Integrating functional imaging in clinical trials (2015) (0)
In Vitro cellular response of head and neck squamous cell lines exposed to combined docetaxel-radiotherapy (2008) (0)
PET-tracer for radiotherapy respons: preclinical investigations (2008) (0)
K6. This house believes that Radiation Oncology should be conformal, tailored and adaptive for the treatment of head and neck tumors (2011) (0)
Pathology-based verification of head and neck imaging: how far are we from the truth and what are the implications for 3D-CRT and IMRT? (2003) (0)
SP-0526: Translating hypoxia imaging into adaptive radiotherapy (2014) (0)
[Comparison of Early Repair Kinetics for Intestine and Lung in Mice After Neutron and Gamma-irradiation] (1985) (0)
Multi-modality imaging (Computed Tomography, Magnetic Resonance Imaging and Positron Emission Tomography) for radiotherapy planning of pharyngo-laryngeal tumors (2004) (0)
Molecular image guided radiotherapy (2018) (0)
Independent external validation using the EORTC HNCG-ROG 1219 DAHANCA trial data of NTCP models for acute oral mucositis. (2021) (0)
71 poster: Iron Oxide Particles Covered with Hexapeptides Targeted at Phosphatidylserine as MR Biomarkers of Tumor Cell Death (2010) (0)
46 Therapeutic strategies in t& No Mo glottic carcinomas. A retrospective evaluation (1996) (0)
Set up accuracy of patients with head and neck tumors using the megavoltage computed tomography imaging capacity of the helical tomotherapy system (2007) (0)
EP-1923: Integration of microscopic spread and geometric uncertainties into a single target volume expansion (2018) (0)
MO‐D‐J‐6C‐03: Pathology‐Based Validation of Head and Neck Imaging: How Far Are We From the Truth? (2005) (0)
SP-0279: The radiation oncologist's view on medical physicists! (2015) (0)
Principles of radiotherapy (2017) (0)
SP-013 TNM8: How has the dust settled one year later? (2019) (0)
Molecular image-guided radiotherapy with positron emission tomography (2009) (0)
Clinical validation of twelve deformable registration strategies in adaptive radiation therapy for head and neck cancer patients (2008) (0)
3:22 pm Response of Endogenous MRI Contrast Metrics (ADC, T2) During Radiotherapy for Prostate Cancer - W. Foltz*, A. Wu, C. Catton, (2010) (0)
POSTER: PHYSICS TRACK: IMPLEMENTATION OF TECHNOLOGY, TECHNIQUES, CLINICAL PROTOCOLS OR TRIALSPO-0877: QA for radiation therapy in a prospective head & neck study: Outcome impact of ICRs performed by the EORTC QART program (2013) (0)
Syddansk Universitet Role of radiotherapy fractionation in head and neck cancers ( MARCH ) an updated meta-analysis (2017) (0)
682 Validation of CT-based Rotterdam/Brussels neck nodal delineation protocol cranial boundary of level II and relevance for sparing of the parotid gland (2003) (0)
No statistical impact of intra-tumoral overexpression of EGFR, VEGF and p53 on the overall survival in head and neck squamous cell cancer (HNSCC): Preliminary results of the GORTEC 99–02 randomized trial (2007) (0)
In reply to "A Long-Awaited Guideline for the Delineation of Primary Tumor in Head and Neck Cancer, and a Few Concerns about It" by Sezin Yuce Sari et al. (2018) (0)
Management of recurrent and metastatic squamous cell carcinoma of the head and neck (2013) (0)
Chapter 25 Impact of Oxygenation Status on 18 F-FDG Uptake in Solid Tumors (2016) (0)
PO-0708: Quality assurance of radiotherapy in the EORTC 1420 Best-of trial. Preliminary results (2018) (0)
8515 POSTER DISCUSSION A Dose Escalation Study With Intensity Modulated Radiation Therapy (IMRT) in Moderately Advanced (T2N0, T2N1, T3N0) Squamous Cell Carcinomas (SCC) of the Oropharynx, Larynx and Hypopharynx Using a Simultaneous Integrated Boost (SIB) Approach (2011) (0)
[Cell-survival Curves - Determining Factors, Models and Concepts] (1994) (0)
Very Accelerated Radiotherapy (RT) Versus Concomitant Chemo-Radiotherapy (Ct-Rt) In Locally Advanced Head And Neck Cancer: Long Term Results From 2 Phases III GORTEC Randomized Trials (2011) (0)
4D validation of dynamic treatment delivery for lung tumors (2012) (0)
OC-0609: Patient specific plan QA for clinical trial EORTC 1219 using Knowledge-Based Planning (2018) (0)
SP-0609 INTENSITY MODULATED RADIATION THERAPY (IMRT) FOR HEAD & NECK TUMORS: TOWARD TAILORED AND ADAPTIVE TREATMENTS (2012) (0)
[Microcinematographic study of the lengthening of the cell cycle after x-ray and fast neutron irradiation]. (1985) (0)
440 poster A GRADIENT-BASED SEGMENTATION METHOD FOR FDG-PET BASED GTV DELINEATION: CLINICAL VALIDATION IN NSCLC (2011) (0)
"Are some green apples less green than others?" (2020) (0)
Dose painting by numbers: a universal method to ensure the robustness of heterogeneous prescriptions against geometric uncertainties (2013) (0)
Head and neck proton therapy in France: A missed opportunity or a challenge in front of us? (2021) (0)
WE-D-BRD-01: Imaging and Treatment Planning for Adaptive Radiotherapy in the Head and Neck (2009) (0)
18F-radiolabeling: New methodology and application to hypoxia-related tracers (2009) (0)
PET-FDG affects staging and patient management in head and neck cancer. A multi-center prospective study (2008) (0)
TH‐C‐214‐04: This House Believes That the Use of Functional Imaging for Treatment Planning of Head and Neck Tumors Needs to Be Carefully Considered (2011) (0)
Concomitant association of CDDP-5Fu and radiotherapy for locally advanced laryngeal and pharyngeal squamous cell carcinomas (SCC). A phase II study (1999) (0)
Topic: PET and RadiotherapyInvited ConferenceIntegration of PET information in Radiation Therapy: present and future clinical applications (2011) (0)
Target Definition and Delineation CT/MRI/PET-Guided Targets (2009) (0)
105 poster: Captopril and S-Nitrosocaptopril as Potent Radiosensitizers: Comparative Study and Underlying Mechanisms. (2010) (0)
Evidence-based approach to determine meaningful change in scores of the EORTC QLQ-C30 in breast and head and neck cancer : on behalf of the EORTC Breast, Head and Neck and Quality of Life Groups (2018) (0)
PD-0868 Comparison of segmentation algorithms for organs at risk delineation on head-and-neck CT images (2021) (0)
RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison (2013) (0)
81: Adaptive radiotherapy for head & neck squamous cell carcinoma (2014) (0)
SP-0227: The immune landscape and immunotherapy for head and neck cancer (2018) (0)
PD-0134: Hypoxia imaging with 18F-FAZA-PET-CT for adaptive escalation dose for head and neck cancer: A planning study (2014) (0)
Abstract 4896: Identification of the mechanisms of radiosensitization by human papillomavirus (HPV) in head and neck cancers cell lines (2014) (0)
Fast Helical Tomotherapy in a head and neck cancer planning study: is time priceless? (2015) (0)
1106TiPHope for salivary gland cancer (SGC): EORTC HNCG/UKCRN 1206 randomized phase II study to evaluate the efficacy and safety of Chemotherapy (CT) vs androgen deprivation therapy (ADT) in patients with recurrent and/or metastatic androgen receptor (AR) expressing SGC (2017) (0)
High frequency of SDHB mutations in a series of head and neck paraganglioma from Belgium (2006) (0)
582 speaker ADAPTIVE TREATMENT WITH HI-ART TOMOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (2011) (0)
Atlas-based automatic segmentation (ABAS) of head structures in conformal radiation therapy (CRT): atlas development and preliminary results in clinical context (2007) (0)
1105TiPPembrolizumab plus chemoradiation (CRT) for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Phase 3 KEYNOTE-412 trial (2017) (0)
Figure 1 : An Overview of the Recent Evolution in External Beam Radiotherapy (2014) (0)
OC-0522 Cell-Rad: Towards Histology-driven Radiation Oncology from Multi-Parametric MRI (2021) (0)
Conservative treatment with combined chemo-radiotherapy for patients with locally advanced pharyngo-laryngeal squamous cell carcinoma: Preserving the organ and its function (2006) (0)
PO-0951: 18F-FAZA PET as a prognostic marker of the response to radiotherapy in rat tumor models (2014) (0)
Results of selective neck dissection in the management of head and neck squamous cell carcinoma (2007) (0)
Tumour shrinkage and adaptive IMRT for head and neck tumor (HNSCC): Where do we stand? (2006) (0)
Management fo recurrent and metastatic sqamous cell carcinoma of the head and neck (2014) (0)
EP-1608: FDG-PET based dose painting in head and neck tumors: a dosimetric comparison between TomoTherapy and RapidArc (2014) (0)
178Effect of 2′,2′-difluorodeoxycytidine (dFdC) on in vitro radiosensitivity of a radioresistant SQD9 human head and neck squamous carcinoma cell line (1996) (0)
[Time-lapse Microcinematographic Study of the Cell-cycle Lengthening After Gamma and Fast-neutron Irradiation] (1985) (0)
Abstract C220: Combining novel targeted therapies and radiotherapy: A challenge to overcome. (2013) (0)
Adaptive radiotherapy to treatment response (2009) (0)
Preclinical validation of 2-C-11-thymidine as a cell proliferation marker, in a murine tumor model. (1999) (0)
174 Re-assessment of hnscc tumor volume during radiotherapy with anatomic and functional imaging (2006) (0)
Bone cell vitality around dental implants after irradiation: an experimental study in dog mandibles. (2002) (0)
SP-0378: PET for delineation in radiotherapy: Reliability and opportunities (2013) (0)
Evidence against the necessity to dissect the apex of level V in head and neck cancer (2004) (0)
Hope for salivary gland cancer (SGC): EORTC HNCG/UKCRN 1206 randomized phase II study to evaluate the efficacy and safety of chemotherapy (CT) vs androgen deprivation therapy (ADT) inpatients with recurrent and/or metastatic androgen receptor (AR) expressing SGC (NCT01969578). (2018) (0)
SP-0522: Dose prescription and treatment delivery at the voxel scale: a fantasy? (2016) (0)
WHICH IMAGING IS NEEDED FOR PLANNING H&N SQUAMOUS CELL CARCINOMA (2009) (0)
22 INVITED Planned neck dissection after chemoradiation for advanced head and neck cancer. Is it always indicated (2007) (0)
Prospective validation of an institutional treatment strategy for T1N0M0 glottic carcinoma (2021) (0)
Impact of imaging on the treatment choice in head and neck cancers (2001) (0)
18FLT-PET for early treatment adaptation and outcome prediction in head and neck tumors (2010) (0)
Registration and segmentation of head and neck volumes in IMRT applications (2008) (0)
349 QUALITY ASSURANCE IN RADIOTHERAPY: THE EORTC EXPERIENCE (2012) (0)
Standard vs. adaptive helical tomotherapy in sparing of parotids - series of exploratory calculations (2007) (0)
Cost-effectiveness in T1N0 glottic squamous cell carcinomas (SCC): Comparison between radiotherapy (RT), laser microsurgery (L) and partial laryngectomy (PL) (1997) (0)
SP-015: Functional Imaging for Selecting and Monitoring Treatments (2013) (0)
[Early cell repair of the lung and the intestine in mice, after irradiation by fast neutrons and gamma rays]. (1986) (0)
Overreactors: definition and value (2008) (0)
Oc-0507 How Many Chemotherapy Cycles During Chemoradiotherapy for Head and Neck Carcinoma? A Gortec Trial (2012) (0)
GENEPI-ENTB 2: an infrastructure for the individualisation of radiotherapy (2009) (0)
Quality assurance of radiotherapy in the ongoing EORTC 1420 “Best of” trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedure (2021) (0)
SP-0623: Basic principles of ICRU concepts applied to IMRT (2013) (0)
Conditioning with 8-Gy total body irradiation for allogeneic haematopoietic stem cell transplantation in acute myeloid leukaemia (2007) (0)
69 Multi-modality imaging for target volume delineation in HNSCC (2006) (0)
PD-0490: Universal method to ensure robustness of dose painting by numbers prescriptions against geometric uncertainties (2013) (0)
Characterization of new SDHD mutations in sporadic and familial head and neck paraganglioma from Belgium (2004) (0)
488 Selective conformal post-operative radiotherapy in patients with head and neck squamous cell carcinoma (HNSCC). Could the “bath of X-rays” be avoided? (2003) (0)
373TiPKEYNOTE-412: Phase 3 trial of pembrolizumab plus chemoradiation (CRT) vs CRT alone for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) (2017) (0)
Identification of intrinsic and induced differential reactivities of tumor arterioles: new bases for therapeutic strategies targeting the tumor vascularization (2003) (0)
Indications of external beams radiation for thyroid cancer (2022) (0)
Adaptive treatment with Hi-Art Tomotherapy for locally advanced head and neck squamous cell carcinoma (2011) (0)
In Regard to Beadle and Anderson. (2018) (0)
PET / CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer : (2015) (0)
SP-0705 Elective nodal irradiation still part of the standard treatment in head and neck cancer (2021) (0)
OC-0681: Deep learning auto contouring of OAR for HN radiotherapy: a blinded evaluation by clinical experts (2020) (0)
Modification of the tumor microenvironment by a plasmid encoding an antiangiogenic factor (2008) (0)
Chapter 38 – Management of the Neck (2012) (0)
[Improvement of the microcinematography technic for the study of cell cycles]. (1984) (0)
[Comparative kinetics of the early repair of intestines and lung in mice after fast neutron and gamma-ray irradiation]. (1985) (0)
Analysis of EGFr, VEGF and p53 in serum of head and neck squamous cell cancer (HNSCC) : Preliminary results of the GORTEC 99-02 randomized trial. (2006) (0)
L’expérimentation animale reste indispensable (OPINION) (2017) (0)
82: An example of the integrated model: the EORTC DAHANCA-1219 trial (2014) (0)
[Multimodalities imaging for target volume definition in radiotherapy]. (2006) (0)
Design and use of patient-specific atlases for radiotherapy planning of the head and neck region (2010) (0)
A comparative study of MRI diffusion-related parameters for the early detection of radiation-induced tissue changes in a rodent tumour model (2009) (0)
Target volume definition in head and neck squamous cell carcinoma: value of functional imaging (2004) (0)
Magnetic Resonance Imaging Virtual Histopathology from Weakly Paired Data (2021) (0)
Hypoxia and perfusion in human head and neck tumors: results with immunohistochemical and image analysis methods employing pimonidazole and IdUrd (2003) (0)
[Early Repair for Lung and Intestine, in Mice, After Neutron and Gamma-irradiation] (1986) (0)
SU-E-T-774: on the Effects of Intrafraction Motion on TomoTherapy SIB Treatments of Lung Tumors: A 4D Monte Carlo Study including Non-Rigid Registration and Beamlet-Breathing Phase Correlation (2011) (0)
Role of chemotherapy in 5 000 patients with head and neck cancer treated by curative surgery: a subgroup analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer (2020) (0)
PO-0646: Adaptive and robust FDG-PET-based dose painting by numbers (DPBN) in head and neck tumors: a methodological approach (2015) (0)
SP-0188: General introduction to head and neck radiotherapy (2016) (0)
90 speaker LOCALIZE THE ENEMY: IMAGING IN H&N CANCER (2011) (0)
Do all the linear accelerators comply with the ICRU 91's constraints for stereotactic body radiation therapy treatments? (2019) (0)
The use of PET imaging for adaptive radiotherapy: Strength and limitation assessed in animal model (2008) (0)
Multi-modal imaging for dose planning and its benefits: the paradigm of head and neck tumours (2018) (0)
Comments on the Publication by Corkum et al on “Does 5 + 5 mm Equal Better Radiation Treatment Plans in Head and Neck Cancers?” (2020) (0)
Calcified tissues histogenesis around dental implants placed in irradiated dog's mandibles. (2000) (0)
Radiobiological and clinical issues in IMRT for head and neck tumors: what are the important data for biological optimization? (2003) (0)
Graphical contents list (2013) (0)
CT-based delineation of lymph node levels and related CTVs in the node-positive and the post-operative neck (2004) (0)
PO-0788 FEASIBILITY STUDY ON FDG-PET BASED ESCALATED DOSE PAINTING IN HEAD AND NECK TUMORS WITH HELICAL TOMOTHERAPY (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Vincent Grégoire?

Vincent Grégoire is affiliated with the following schools:

Université catholique de Louvain

Vincent Grégoire's Academic­Influence.com Rankings

Why Is Vincent Grégoire Influential?

Vincent Grégoire's Published Works

Published Works

What Schools Are Affiliated With Vincent Grégoire?

Vincent Grégoire's AcademicInfluence.com Rankings